Celecoxib Patent Expiration

Celecoxib is Used for reducing inflammation and treating various types of arthritis. It was first introduced by Upjohn Us 2 Llc in its drug Celebrex on Dec 31, 1998. Other drugs containing Celecoxib are Elyxyb, Vyscoxa. 29 different companies have introduced drugs containing Celecoxib.


Celecoxib Patents

Given below is the list of patents protecting Celecoxib, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Elyxyb US10376527 Oral composition of celecoxib for treatment of pain May 27, 2036 Scilex Pharms
Elyxyb US10722456 Oral composition of celecoxib for treatment of pain May 27, 2036 Scilex Pharms
Elyxyb US10799517 Oral composition of celecoxib for treatment of pain May 27, 2036 Scilex Pharms
Elyxyb US9572819 Oral composition of celecoxib for treatment of pain May 27, 2036 Scilex Pharms
Elyxyb US9795620 Oral composition of celecoxib for treatment of pain May 27, 2036 Scilex Pharms
Elyxyb US9949990 Oral composition of celecoxib for treatment of pain May 27, 2036 Scilex Pharms
Celebrex US5760068

(Pediatric)

Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation Dec 02, 2015

(Expired)

Upjohn
Celebrex USRE44048

(Pediatric)

4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonamide for the treatment of inflammation or an inflammation-associated disorder Dec 02, 2015

(Expired)

Upjohn
Celebrex US5760068 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation Jun 02, 2015

(Expired)

Upjohn
Celebrex USRE44048 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonamide for the treatment of inflammation or an inflammation-associated disorder Jun 02, 2015

(Expired)

Upjohn
Celebrex US5466823

(Pediatric)

Substituted pyrazolyl benzenesulfonamides May 30, 2014

(Expired)

Upjohn
Celebrex US5563165

(Pediatric)

Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation May 30, 2014

(Expired)

Upjohn
Celebrex US5466823 Substituted pyrazolyl benzenesulfonamides Nov 30, 2013

(Expired)

Upjohn
Celebrex US5563165 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation Nov 30, 2013

(Expired)

Upjohn



Celecoxib's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Celecoxib Generic API Manufacturers

Several generic applications have been filed for Celecoxib. The first generic version for Celecoxib was by Teva Pharmaceuticals Usa Inc and was approved on May 30, 2014. And the latest generic version is by Zydus Pharmaceuticals Usa Inc and was approved on Jul 14, 2025.

Given below is the list of companies who have filed for Celecoxib generic, along with the locations of their manufacturing plants worldwide.


Celecoxib News

Patent Extensions Result in $3.5 Billion Loss in Potential Generic Savings for the US

22 Aug, 2025

NeuroSense Therapeutics is nearing a significant pharmaceutical agreement with its ALS treatment...

24 Apr, 2025

See More